Sources of systematic error in DCE‐MRI estimation of low‐level blood‐brain barrier leakage
Cameron Manning, Michael Stringer, Ben Dickie, Úna Clancy, Maria C. Valdés Hernández, Stewart Wiseman, Daniela Jaime García, Eleni Sakka, Walter H. Backes, Michael Ingrisch, Francesca M. Chappell, Fergus Doubal, Craig Buckley, Laura M. Parkes, Geoff J.M. Parker, Ian Marshall, Joanna M. Wardlaw, Michael J. Thrippleton
Abstract
Purpose Dynamic contrast‐enhanced (DCE) ‐MRI with Patlak model analysis is increasingly used to quantify low‐level blood‐brain barrier (BBB) leakage in studies of pathophysiology. We aimed to investigate systematic errors due to physiological, experimental, and modeling factors influencing quantification of the permeability‐surface area product PS and blood plasma volume v p , and to propose modifications to reduce the errors so that subtle differences in BBB permeability can be accurately measured. Methods Simulations were performed to predict the effects of potential sources of systematic error on conventional PS and v p quantification: restricted BBB water exchange, reduced cerebral blood flow, arterial input function (AIF) delay and error. The impact of targeted modifications to the acquisition and processing were evaluated, including: assumption of fast versus no BBB water exchange, bolus versus slow injection of contrast agent, exclusion of early data from model fitting and correction. The optimal protocol was applied in a cohort of recent mild ischaemic stroke patients. Results Simulation results demonstrated substantial systematic errors due to the factors investigated (absolute PS error ≤ 4.48 × 10 −4 min −1 ). However, these were reduced (≤0.56 × 10 −4 min −1 ) by applying modifications to the acquisition and processing pipeline. Processing modifications also had substantial effects on in‐vivo normal‐appearing white matter PS estimation (absolute change ≤ 0.45 × 10 −4 min −1 ). Conclusion Measuring subtle BBB leakage with DCE‐MRI presents unique challenges and is affected by several confounds that should be considered when acquiring or interpreting such data. The evaluated modifications should improve accuracy in studies of neurodegenerative diseases involving subtle BBB breakdown.